261 related articles for article (PubMed ID: 25952734)
21. Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.
England CG; Ehlerding EB; Hernandez R; Rekoske BT; Graves SA; Sun H; Liu G; McNeel DG; Barnhart TE; Cai W
J Nucl Med; 2017 Jan; 58(1):162-168. PubMed ID: 27493273
[TBL] [Abstract][Full Text] [Related]
22. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
Yoshizawa H; Chang AE; Shu SY
Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
[TBL] [Abstract][Full Text] [Related]
23. A novel murine model for the assessment of human CD2-related reagents in vivo.
Ding Y; Qin L; Yang Q; Punch JD; Fox DA; Hochman PS; Bromberg JS
J Immunol; 1996 Sep; 157(5):1863-9. PubMed ID: 8757303
[TBL] [Abstract][Full Text] [Related]
24. alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses.
Fujihashi K; Yamamoto M; McGhee JR; Kiyono H
J Immunol; 1993 Dec; 151(12):6681-91. PubMed ID: 7903096
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice.
Samira S; Ferrand C; Peled A; Nagler A; Tovbin Y; Ben-Hur H; Taylor N; Globerson A; Lapidot T
Stem Cells; 2004; 22(6):1085-100. PubMed ID: 15536198
[TBL] [Abstract][Full Text] [Related]
26. Imaging T Cells In Vivo.
Neri D
J Nucl Med; 2015 Aug; 56(8):1135-6. PubMed ID: 25999430
[No Abstract] [Full Text] [Related]
27. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
28. Removal of Fc Glycans from [
White JM; Keinänen OM; Cook BE; Zeglis BM; Gibson HM; Viola NT
Mol Pharm; 2020 Jun; 17(6):2099-2108. PubMed ID: 32330387
[TBL] [Abstract][Full Text] [Related]
29. Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.
Rashidian M; Ingram JR; Dougan M; Dongre A; Whang KA; LeGall C; Cragnolini JJ; Bierie B; Gostissa M; Gorman J; Grotenbreg GM; Bhan A; Weinberg RA; Ploegh HL
J Exp Med; 2017 Aug; 214(8):2243-2255. PubMed ID: 28666979
[TBL] [Abstract][Full Text] [Related]
30. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
31. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
Sykes M
Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
[TBL] [Abstract][Full Text] [Related]
32. In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue.
Griessinger CM; Kehlbach R; Bukala D; Wiehr S; Bantleon R; Cay F; Schmid A; Braumüller H; Fehrenbacher B; Schaller M; Eichner M; Sutcliffe JL; Ehrlichmann W; Eibl O; Reischl G; Cherry SR; Röcken M; Pichler BJ; Kneilling M
J Nucl Med; 2014 Feb; 55(2):301-7. PubMed ID: 24434289
[TBL] [Abstract][Full Text] [Related]
33. The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection.
Kasaian MT; Leite-Morris KA; Biron CA
J Immunol; 1991 Mar; 146(6):1955-63. PubMed ID: 1672337
[TBL] [Abstract][Full Text] [Related]
34. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
Drobyski WR; Majewski D; Ozker K; Hanson G
J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
[TBL] [Abstract][Full Text] [Related]
36. The Production, Quality Control, and Characterization of ZED8, a CD8-Specific
Gill H; Seipert R; Carroll VM; Gouasmat A; Yin J; Ogasawara A; de Jong I; Phan MM; Wang X; Yang J; Ilovich O; Marik J; Williams SP
AAPS J; 2020 Jan; 22(2):22. PubMed ID: 31900688
[TBL] [Abstract][Full Text] [Related]
37. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
[TBL] [Abstract][Full Text] [Related]
38. TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation.
Ahmed RK; Poiret T; Ambati A; Rane L; Remberger M; Omazic B; Vudattu NK; Winiarski J; Ernberg I; Axelsson-Robertson R; Magalhaes I; Castelli C; Ringden O; Maeurer M
J Immunother; 2014 Oct; 37(8):416-25. PubMed ID: 25198529
[TBL] [Abstract][Full Text] [Related]
39. Antigen dose-dependent suppression of murine IgE responses is mediated by CD4(-)CD8(-) double-negative T cells.
Barwig C; Raker V; Montermann E; Grabbe S; Reske-Kunz AB; Sudowe S
Clin Exp Allergy; 2010 Jun; 40(6):891-901. PubMed ID: 20214662
[TBL] [Abstract][Full Text] [Related]
40. Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody.
van Rij CM; Sharkey RM; Goldenberg DM; Frielink C; Molkenboer JD; Franssen GM; van Weerden WM; Oyen WJ; Boerman OC
J Nucl Med; 2011 Oct; 52(10):1601-7. PubMed ID: 21865288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
